Obesity drugs can help people drink low alcohol: study

A new survey suggests that using weight loss drugs such as Ojampic and Wagovi can use less alcohol.

In this survey published by Jama Psychiatry on Wednesday, 48 people saw the medical journal “non-treatment-seekers” participant who described alcohol use disorder (ADD). Half of the participants were given semaglutide for nine weeks of weight loss drugs. Others got a plusbo.

At the end of the study period, both groups were presented with their favorite alcohol, but the option was given to reject the drink for a minimum of 50 minutes to get “financial reinforcement”. Following the break, the participants were instructed to take the drink “at their choice speed” every two hours in the survey.

Researchers, after the test, found that those who took low dose semaglotid drank less alcohol than those with placebo.

“More than 9 weeks of treatment, semaglutide has decreased in some things, but not all weekly use arrangements, relatively weekly alcohol thirst has significantly reduced the thirst of alcohol, and the current cigarette use of the current cigarette causes more relative reduction in cigarettes,” Jama Study.

Weight loss drums such as Ozampic, Wagovi and Jepbound work by imitating a hormone called GLP -1 that stimulate insulin emissions and can also reduce appetite. The drugs approved for the treatment of diabetes are also known to help deal with obesity.

Last year, another study published in Jama Psychiatry showed that semagloted drugs were reduced to a hospital-related hospital with ADD and Type 2 diabetes for a group of Sweden.

Drugs are also known to reduce the risk of other treatment related problems, including the risk of potential death from Covid -19.